[1]
J. SANKARAIAH, N. SHARMA, and M. J. NAIM, “FORMULATION AND DEVELOPMENT OF FIXED-DOSE COMBINATION OF BI-LAYER TABLETS OF EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLETS 600 MG/300 MG/300 MG”, Int J App Pharm, vol. 14, no. 1, pp. 185–197, Jan. 2022.